EED and diabetes mellitus: Importantly, Eed KO, which abrogates PRC2 enzymatic and reader capacities, resulted in transcriptional and pathophysiological changes that recapitulate human and mouse β cell dysfunction and diabetes, namely dysregulation of bivalent and chromatin state A embedded genes, and progressive loss of terminal β cell identity.